OC
TMDX icon

Oppenheimer & Co’s Transmedics TMDX Stock Holding History

Oppenheimer & Co’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3M Sell
113,472
-3,094
-3% -$404K 0.14% 158
2025
Q4 		$14.2M Buy
116,566
+4,926
+4% +$618K 0.2% 102
2025
Q3 		$12.5M Sell
111,640
-5,730
-5% -$671K 0.15% 139
2025
Q2 		$15.7M Buy
117,370
+39,368
+50% +$4.32M 0.21% 98
2025
Q1 		$5.25M Buy
78,002
+14,578
+23% +$1M 0.08% 274
2024
Q4 		$3.95M Buy
63,424
+18,531
+41% +$1.72M 0.06% 346
2024
Q3 		$7.05M Buy
44,893
+2,748
+7% +$423K 0.11% 206
2024
Q2 		$6.35M Buy
42,145
+15,575
+59% +$1.87M 0.1% 222
2024
Q1 		$1.96M Buy
26,570
+16,214
+157% +$1.34M 0.03% 525
2023
Q4 		$817K Buy
10,356
+1,365
+15% +$82.3K 0.02% 780
2023
Q3 		$492K Sell
8,991
-3,599
-29% -$259K 0.01% 950
2023
Q2 		$1.06M Buy
12,590
+1,162
+10% +$89K 0.02% 685
2023
Q1 		$865K Buy
11,428
+1,602
+16% +$111K 0.02% 740
2022
Q4 		$606K Sell
9,826
-2,695
-22% -$143K 0.01% 858
2022
Q3 		$523K Buy
12,521
+2,981
+31% +$130K 0.01% 880
2022
Q2 		$300K Hold
9,540
– – 0.01% 1111
2022
Q1 		$257K Buy
+9,540
New +$171K ﹤0.01% 1264

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oppenheimer & Co's TMDX Position: Q1 2026 in Review

Oppenheimer & Co reduced its Transmedics (TMDX) stake by 2.7% in Q1 2026, selling an estimated $404K and leaving 113,472 shares worth $11.3M. The position accounts for 0.14% of the portfolio, ranked #158.

Oppenheimer & Co first reported a position in TMDX in Q1 2022 and has held it in 17 quarters since. The position peaked at $15.7M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Oppenheimer & Co held 113,472 shares of Transmedics worth $11.3M as of Q1 2026.
  • Oppenheimer & Co sold 3,094 Transmedics shares in Q1 2026, an estimated $404K.
  • Transmedics made up 0.14% of Oppenheimer & Co's portfolio in Q1 2026, its #158 holding.
  • Oppenheimer & Co first reported a position in Transmedics in Q1 2022 and has held it in 17 quarters since.
  • Oppenheimer & Co's Transmedics position peaked at $15.7M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.